Treatment of Wilson disease with ammonium tetrathiomolybdate: II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy

Archives of Neurology

Volumn 53, Issue 10, 1996, Pages 1017-1025

  Brewer, George J ^a   Johnson, Virginia ^a   Dick, Robert D ^a   Kluin, Karen J ^a   Fink, John K ^a   Brunberg, James A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLAMINE; TETRATHIOMOLYBDATE AMMONIUM;

ANEMIA; ARTICLE; BRAIN SCINTISCANNING; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WILSON DISEASE;

EID: 0029821201     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550100103019     Document Type: Article

References (21)

1. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine. 1992;71:39-164.
2. Owen CA Jr. Wilson's Disease: The Etiology, Clinical Aspects, and Treatment of Inherited Copper Toxicosis. Park Ridge, NJ: Noyes Publications; 1981.
3. Scheinberg IH, Sternlieb I. Wilson's disease. In: Smith LH Jr, ed. Major Problems in Internal Medicine. Philadelphia, Pa: WB Saunders Co; 1984:23.
4. Williams DM, Lee GR. Hepatolenticular degeneration (Wilson's disease). In: Powell LW, ed. Metals and the Liver. New York, NY: Marcel Dekker; 1978: 241-311.
5. Walshe JM. Penicillamine: a new oral therapy for Wilson's disease. Am J Med. 1956;21:487-495.
6. Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of neurological syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol. 1987;44:490-494.
7. Nimni ME, Bavetta LA. Collagen defect induced by penicillamine. Science. 1965; 150:905-907.
8. Ronchetti IP, Quaglino D Jr, Contri MB, Hayek J, Galassi G. Dermal alterations in patients with Wilson's disease treated with D-penicillamine. J Submicrosc Cytol Pathol. 1989;21:131-139.
9. Ronchetti IP, Fornieri C, Contri MB, Quaglino D Jr, Caselgrandi E. Effect of DL-penicillamine on the aorta of growing chickens. Am J Pathol. 1986;124: 436-447.
10. Halverson PB, Kozin F, Bernhard GC, Goldman AL. Toxicity of penicillamine: a serious limitation to therapy in rheumatoid arthritis. JAMA. 1978;240:1870-1871.
11. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson's disease: an update, with emphasis on new approaches to treatment. Dig Dis. 1989;7:178-193.
12. Walshe JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet. 1982;1:643-647.
13. Hoogenraad TU, Koevoet R, De Ruyter Korver EGWM. Oral zinc sulfate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 1979;18:205-211.
14. Hoogenraad TU, Van Hattum J, Van den Hamer CJA. Management of Wilson's disease with zinc sulfate: experience in a series of 27 patients. J Neurol Sci. 1987;77:137-146.
15. Brewer GJ, Hill GM, Prasad AS, Cossack ZT, Rabbani P. Oral zinc therapy for Wilson's disease. Ann Intern Med. 1983;99:314-320.
16. Hill GM, Brewer GJ, Prasad AS, Hydrick CR, Hartmann DE. Treatment of Wilson's disease with zinc, I: oral zinc therapy regimens. Hepatology. 1987;7: 522-528.
17. Brewer GJ, Dick RD, Johnson V, et al. Treatment of Wilson's disease with ammonium tetrathiomolybdate, I: initial therapy in 17 neurologically affected patients. Arch Neurol. 1994;51:545-554.
18. Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, et al. Initial therapy of patients with Wilson's disease with tetrathiomolybdate. Arch Neurol. 1991;48:42-47.
19. Brewer GJ, Hill GM, Dick RD, et al. Treatment of Wilson's disease with zinc, III: prevention of reaccumulation of hepatic copper. J Lab Clin Med. 1987;109: 526-531.
20. Brewer GJ, Hill GM, Prasad AS, Dick RD. The treatment of Wilson's disease with zinc, IV: efficacy monitoring using urine and plasma copper. Proc Soc Exp Biol Med. 1987;7:446-455.
21. Harper PI, Walshe JM. Reversible pancytopenia secondary to treatment with tetrathiomolybdate. Br J Haematol. 1986;64:851-853.